ApoGen Biotechnologies' Series A - II Round

ApoGen Biotechnologies raised a round of funding on August 23, 2018. Investors include Merck Ventures.

ApoGen Biotechnologies is a biotechnology company focused on the development of therapeutics targeting drivers of cancer genomic mutation. ApoGen is building upon technologies developed at the Univers…

Articles about ApoGen Biotechnologies' Series A - II Round: